PILOPINE HS
LOE ApproachingNDAOPHTHALMICGEL
Approved
Oct 1984
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed Yesterday · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PILOPINE HS is a small-molecule ophthalmic gel approved in 1984 for eye care, likely containing pilocarpine as its active ingredient. The product treats ocular conditions through topical application to the eye. It represents a classic, mature therapeutic agent in the ophthalmology space.
LOE Approaching
Product is in late-stage lifecycle with moderate competitive pressure (30%), signaling small, focused brand teams managing decline or maintenance mode operations.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on PILOPINE HS offers limited growth trajectory; roles focus on defending market position and managing operational efficiency in a mature, competitive market. Career development opportunities are constrained by the product's LOE-approaching status and zero linked job openings.
Brand ManagerField Sales Representative
Worked on PILOPINE HS at Alcon? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.